These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32761088)

  • 1. HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol.
    van der Boom T; Jia C; Lefrandt JD; Connelly MA; Links TP; Tietge UJF; Dullaart RPF
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3355-62. PubMed ID: 32761088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort.
    Pearce EN; Wilson PW; Yang Q; Vasan RS; Braverman LE
    J Clin Endocrinol Metab; 2008 Mar; 93(3):888-94. PubMed ID: 18073305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.
    Sigal GA; Tavoni TM; Silva BMO; Kalil Filho R; Brandão LG; Maranhão RC
    Thyroid; 2019 Jan; 29(1):53-58. PubMed ID: 30412041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function.
    Jung KY; Ahn HY; Han SK; Park YJ; Cho BY; Moon MK
    J Clin Lipidol; 2017; 11(6):1347-1353. PubMed ID: 28958565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
    Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
    Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
    Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy.
    Caron P; Calazel C; Parra HJ; Hoff M; Louvet JP
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):519-23. PubMed ID: 2121398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships between thyroid functions of short-term rapid hypothyroidism and blood lipid levels in post-thyroidectomy patients of differentiated thyroid cancer.
    Yao J; Zhao J; Liu J; Jiang S; Guo S; Xu L; Zhang X; Sheng Q; Wang K; Liao L; Dong J
    Front Endocrinol (Lausanne); 2023; 14():1114344. PubMed ID: 37181036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma branched chain amino acids are lower in short-term profound hypothyroidism and increase in response to thyroid hormone supplementation.
    van der Boom T; Gruppen EG; Lefrandt JD; Connelly MA; Links TP; Dullaart RPF
    Scand J Clin Lab Invest; 2020 Nov; 80(7):562-566. PubMed ID: 32838571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies.
    Tanis BC; Westendorp GJ; Smelt HM
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):643-9. PubMed ID: 8759176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thyroid function on pre-β1 high-density lipoprotein levels in patients with Graves' disease undergoing radioiodine treatment.
    Cai Z; Deng L; Chen Y; Ling Y
    Endocrine; 2022 Jun; 76(3):648-659. PubMed ID: 35235144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.